AAAAAA
Results: 1-25/35
Authors:
DOGLIOTTI L
DANESE S
BERRUTI A
ZOLA P
BUNIVA T
BOTTINI A
RICHIARDI G
MORO G
FARRIS A
BAU MG
PORCILE G
Citation: L. Dogliotti et al., CISPLATIN, EPIRUBICIN, AND LONIDAMINE COMBINATION REGIMEN AS FIRST-LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(4), 1998, pp. 333-338
Authors:
MAGGINO T
ROMAGNOLO C
LANDONI F
SARTORI E
ZOLA P
GADDUCCI A
Citation: T. Maggino et al., AN ANALYSIS OF APPROACHES TO THE MANAGEMENT OF ENDOMETRIAL CANCER IN NORTH-AMERICA - A CTF STUDY, Gynecologic oncology, 68(3), 1998, pp. 274-279
Authors:
GADDUCCI A
SARTORI E
MAGGINO T
ZOLA P
LANDONI F
FANUCCHI A
PALAI N
ALESSI C
FERRERO AM
COSIO S
CRISTOFANI R
Citation: A. Gadducci et al., ANALYSIS OF FAILURES AFTER NEGATIVE 2ND-LOOK IN PATIENTS WITH ADVANCED OVARIAN-CANCER - AN ITALIAN MULTICENTER STUDY, Gynecologic oncology, 68(2), 1998, pp. 150-155
Authors:
MICHELETTI L
PRETI M
ZOLA P
VALENTINO MCZ
BOCCI G
BOGLIATTO F
Citation: L. Micheletti et al., A PROPOSED GLOSSARY OF TERMINOLOGY RELATED TO THE SURGICAL-TREATMENT OF VULVAR CARCINOMA, Cancer, 83(7), 1998, pp. 1369-1375
Authors:
PENNA A
GRILLI R
FILARDO G
MAININI F
ZOLA P
MANTOVANI L
LIBERATI A
Citation: A. Penna et al., DO DIFFERENT PHYSICIANS PANELS REACH SIMILAR CONCLUSIONS - A CASE-STUDY ON PRACTICE GUIDELINES FOR LIMITED SURGERY IN BREAST-CANCER, European journal of public health, 7(4), 1997, pp. 436-440
Authors:
GADDUCCI A
SARTORI E
MAGGINO T
ZOLA P
LANDONI F
FANUCCHI A
STEGHER C
ALESSI C
BUTTITTA F
BERGAMINO T
Citation: A. Gadducci et al., ANALYSIS OF FAILURES IN PATIENTS WITH STAGE-I OVARIAN-CANCER - AN ITALIAN MULTICENTER STUDY, International journal of gynecological cancer, 7(6), 1997, pp. 445-450
Authors:
GADDUCCI A
LANDONI F
MAGGINO T
SARTORI E
ZOLA P
FERDEGHINI M
PARMA G
CRISTOFANI R
Citation: A. Gadducci et al., SERUM CA125 ASSAY AT THE TIME OF RELAPSE HAS NO PROGNOSTIC RELEVANCE IN PATIENTS UNDERGOING CHEMOTHERAPY FOR RECURRENT OVARIAN-CANCER - A MULTICENTER ITALIAN STUDY, International journal of gynecological cancer, 7(1), 1997, pp. 78-83
Authors:
BERRUTI A
ZOLA P
BUNIVA T
BAU MG
FARRIS A
SAROBBA MG
BOTTINI A
TAMPELLINI M
DURANDO A
DESTEFANIS M
MONZEGLIO C
MORO G
SUSSIO M
PERRONI D
DOGLIOTTI L
Citation: A. Berruti et al., PROGNOSTIC FACTORS IN METASTATIC BREAST-CANCER PATIENTS OBTAINING OBJECTIVE RESPONSE OR DISEASE STABILIZATION AFTER FIRST-LINE CHEMOTHERAPYWITH EPIRUBICIN - EVIDENCE FOR A POSITIVE EFFECT OF MAINTENANCE HORMONAL-THERAPY ON OVERALL SURVIVAL, Anticancer research, 17(4A), 1997, pp. 2763-2768
Authors:
SARTORI E
BAZZURINI L
GADDUCCI A
LANDONI F
LISSONI A
MAGGINO T
ZOLA P
LAFACE B
Citation: E. Sartori et al., CARCINOSARCOMA OF THE UTERUS - A CLINICOPATHOLOGICAL MULTICENTER CTF STUDY, Gynecologic oncology, 67(1), 1997, pp. 70-75
Authors:
GADDUCCI A
SARTORI E
ZOLA P
LANDONI F
MAGGINO T
PALAI N
FANUCCHI A
KATSAROS D
Citation: A. Gadducci et al., SERUM CA125 ASSAY IN THE EARLY DIAGNOSIS OF RECURRENT EPITHELIAL OVARIAN-CANCER - A CTF STUDY, Oncology Reports, 3(2), 1996, pp. 301-303
Authors:
DOGLIOTTI L
BERRUTI A
BUNIVA T
ZOLA P
BAU MG
FARRIS A
SAROBBA MG
BOTTINI A
ALQUATI P
DELTETTO F
GOSSO P
MONZEGLIO C
MORO G
SUSSIO M
PERRONI D
Citation: L. Dogliotti et al., LONIDAMINE SIGNIFICANTLY INCREASES THE ACTIVITY OF EPIRUBICIN IN PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Journal of clinical oncology, 14(4), 1996, pp. 1165-1172
Authors:
GRILLI R
PENNA A
ZOLA P
LIBERATI A
Citation: R. Grilli et al., PHYSICIANS VIEW OF PRACTICE GUIDELINES - A SURVEY OF ITALIAN PHYSICIANS, Social science & medicine, 43(8), 1996, pp. 1283-1287
Authors:
GADDUCCI A
LANDONI F
MAGGINO T
SARTORI E
ZOLA P
FANUCCHI A
Citation: A. Gadducci et al., THE RELATIONSHIP BETWEEN POSTOPERATIVE DECLINE OF SERUM CA-125 LEVELSAND SIZE OF RESIDUAL DISEASE AFTER INITIAL SURGERY IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A CTF STUDY, Gynecologic oncology, 63(2), 1996, pp. 234-237
Authors:
GADDUCCI A
SARTORI E
LANDONI F
ZOLA P
MAGGINO T
URGESI A
LISSONI A
LOSA G
FANUCCHI A
Citation: A. Gadducci et al., ENDOMETRIAL STROMAL SARCOMA - ANALYSIS OF TREATMENT FAILURES AND SURVIVAL, Gynecologic oncology, 63(2), 1996, pp. 247-253
Authors:
GADDUCCI A
LANDONI F
SARTORI E
ZOLA P
MAGGINO T
LISSONI A
BAZZURINI L
ARISIO R
ROMAGNOLO C
CRISTOFANI R
Citation: A. Gadducci et al., UTERINE LEIOMYOSARCOMA - ANALYSIS OF TREATMENT FAILURES AND SURVIVAL, Gynecologic oncology, 62(1), 1996, pp. 25-32
Authors:
KATSAROS D
ZOLA P
SINISTRERO G
BERGAMINO T
RUMORE A
FERRERO A
BAU MG
SISMONDI P
Citation: D. Katsaros et al., WEEKLY CISPLATIN INDUCTION CHEMOTHERAPY IN HIGH-RISK CERVICAL-CANCER PATIENTS WITH BULKY TUMOR - A PHASE-II STUDY, International journal of oncology, 6(5), 1995, pp. 1033-1038
Authors:
TRIMBOS JB
ZOLA P
Citation: Jb. Trimbos et P. Zola, THE PRESENT ROLE OF LAPAROSCOPY IN GYNECOLOGICAL ONCOLOGY - THE EORTCPOINT-OF-VIEW, European journal of cancer, 31A(5), 1995, pp. 803-805
Authors:
MAGGINO T
ROMAGNOLO C
ZOLA P
SARTORI E
LANDONI F
GADDUCCI A
Citation: T. Maggino et al., AN ANALYSIS OF APPROACHES TO THE TREATMENT OF ENDOMETRIAL CANCER IN WESTERN-EUROPE - A CTF STUDY, European journal of cancer, 31A(12), 1995, pp. 1993-1997
Authors:
BOCCARDO F
BRUZZI P
CIONINI L
CONFALONIERI C
FOSSATI R
GION M
GIUSEPPETTI GM
PARADISO A
PARMA E
RACANELLI A
DELTURCO MR
SACCOZZI R
SINISTRERO G
ZOLA P
FILARDO G
GRILLI R
Citation: F. Boccardo et al., APPROPRIATENESS OF THE USE OF CLINICAL AND RADIOLOGIC EXAMINATIONS AND LABORATORY TESTS IN THE FOLLOW-UP OF SURGICALLY-TREATED BREAST-CANCER PATIENTS - RESULTS OF THE WORKING GROUP ON THE CLINICAL ASPECTS OF FOLLOW-UP, Annals of oncology, 6, 1995, pp. 57-59
Authors:
SCORPIGLIONE N
NICOLUCCI A
GRILLI R
ANGIOLINI C
BELFIGLIO M
CARINCI F
CUBASSO D
FILARDO G
LABBROZZI D
MAININI F
MARI E
PENNA A
ZOLA P
LIBERATI A
Citation: N. Scorpiglione et al., APPROPRIATENESS AND VARIATION OF SURGICAL-TREATMENT OF BREAST-CANCER IN ITALY - WHEN EXCELLENCE IN CLINICAL RESEARCH DOES NOT MATCH WITH GENERALIZED GOOD QUALITY CARE, Journal of clinical epidemiology, 48(3), 1995, pp. 345-352
Authors:
KATSAROS D
THEILLET C
ZOLA P
LOUASON G
SANFILIPPO B
ISAIA E
ARISIO R
GIARDINA G
SISMONDI P
Citation: D. Katsaros et al., CONCURRENT ABNORMAL EXPRESSION OF ERBB-2, MYC AND RAS GENES IS ASSOCIATED WITH POOR OUTCOME OF OVARIAN-CANCER PATIENTS, Anticancer research, 15(4), 1995, pp. 1501-1510
Authors:
GADDUCCI A
ZOLA P
LANDONI F
MAGGINO T
SARTORI E
BERGAMINO T
CRISTOFANI R
Citation: A. Gadducci et al., SERUM HALF-LIFE OF CA-125 DURING EARLY CHEMOTHERAPY AS AN INDEPENDENTPROGNOSTIC VARIABLE FOR PATIENTS WITH ADVANCED EPITHELIAL OVARIAN-CANCER - RESULTS OF A MULTICENTRIC ITALIAN STUDY, Gynecologic oncology, 58(1), 1995, pp. 42-47
Authors:
LEVESQUE MA
DIAMANDIS EP
YU H
ZOLA P
SISMONDI P
GIARDINA G
KATSAROS D
Citation: Ma. Levesque et al., IMMUNOFLUOROMETRICALLY QUANTIFIED P53 PROTEIN AS A PROGNOSTIC INDICATOR IN OVARIAN-CARCINOMA, Clinical chemistry, 41(6), 1995, pp. 224-224
Authors:
LEVESQUE MA
KATSAROS D
YU H
ZOLA P
SISMONDI P
GIARDINA G
DIAMANDIS EP
Citation: Ma. Levesque et al., MUTANT P53 PROTEIN OVEREXPRESSION IS ASSOCIATED WITH POOR OUTCOME IN PATIENTS WITH WELL OR MODERATELY DIFFERENTIATED OVARIAN-CARCINOMA, Cancer, 75(6), 1995, pp. 1327-1338
Authors:
DOGLIOTTI L
BERRUTI A
BUNIVA T
ZOLA P
BAU MG
FARRIS A
SAROBBA MG
BOTTINI A
ALQUATI P
DELTETTO F
GOSSO P
MONZEGLIO C
MORO G
SUSSIO M
PERRONI D
Citation: L. Dogliotti et al., A RANDOMIZED COMPARISON OF HIGH-DOSE EPIRUBICIN VERSUS HIGH-DOSE EPIRUBICIN PLUS LONIDAMINE IN ADVANCED BREAST-CANCER PATIENTS - FIRST RESULTS FROM A COOPERATIVE GROUP-STUDY, International journal of oncology, 4, 1994, pp. 747-752